Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > CD47 > EP-152

CD47 [Biotinylated] : SIRP alphaV2 Inhibitor Screening ELISA Kit

For research use only.

Order Now

EP152-C01High-bind Plate1 plate
EP152-C02Human SIRP alphaV220 μg
EP152-C03Anti-CD47 Neutralizing Antibody20 μg
EP152-C04Human CD47-Biotin10 μg
EP152-C05Streptavidin-HRP10 μg
EP152-C06Coating Buffer12 mL
EP152-C0710xWashing Buffer 50 mL
EP152-C08Blocking Buffer50 mL
EP152-C09Substrate Solution12 mL
EP152-C10Stop Solution7 mL
  • Background
    CD47 is a transmembrane protein, a cell surface glycoprotein molecule belonging to the immunoglobulin superfamily that binds to a variety of proteins, including integrins, thrombospondin 1, and signal regulatory protein-α (SIRPα). In recent years, accumulating data have demonstrated that the CD47-SIRPαV2 axis is a key immune checkpoint in different cancers, including hematological malignancies, similar to PD-1/PD-L1 in solid tumors. CD47-SIRPαV2 blockade has become a next-generation immune checkpoint blocking strategy for various malignancies after PD-1/PD-L1.
  • Application

    This kit is developed for screening for inhibitors of human CD47 binding to human SIRP alphaV2.

    It is for research use only.

  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new CD47 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human CD47 to immobilized human SIRP alphaV2 in a functional ELISA assay, and employs a simple colorimetric sandwich ELISA platform.

    Your experiment will include 4 simple steps:

    a) Coat the plate with human SIRP alphaV2.

    b) Add your molecule of interest to the tests.

    c) Add human CD47-Biotin to bind the coated human SIRP alphaV2.

    d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

    Finally, the ability of your compound to inhibit CD47 [Biotinylated] : SIRP alphaV2 Rbinding will be determined by comparing OD readings among different experimental groups.

Typical Data Please refer to DS document for The assay protocol.

Serial dilutions of Anti-CD47 Neutralizing Antibody (Catalog # EP152-C03) (1:1 serial dilution, from 10 μg/mL to 0.078 μg/mL (68.493-0.535 nM)) was added into SIRP alphaV2: CD47-Biotin binding reactions. The assay was performed according to the above-described protocol. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

Comments (0)

ETD of in-stock products: 2 business days

Price(USD) : $650.00

Promotion & Exhibitions

Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:49 Details
  • Latest Research Phase:Phase 2 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message